Migraine in Poland - a Web-based Cross-sectional Survey
MIGinPOL2021
1 other identifier
observational
2,800
1 country
2
Brief Summary
A survey of Polish respondents will aim to define migraine characteristics in Polish subjects. To achieve this, a structured questionnaire based mainly on American Migraine Prevalence and Prevention Study has been prepared to serve as a tool for data extraction. The obtained data should allow for defining disease parameters, burden and received treatments. Additionally questions regarding patients rhinological symptoms and COVID-19-related history were included.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2021
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
September 19, 2021
CompletedFirst Posted
Study publicly available on registry
October 21, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 30, 2022
CompletedMay 4, 2022
May 1, 2022
8 months
September 19, 2021
May 3, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Headache phenotype
Classification of reported headache according to International Classification of Headache Disorders
in the preceding year
Migraine burden
Consequences of the disease measured by the Migraine Disability Assessment Test
in the preceding year
Secondary Outcomes (25)
Monthly headache days
in the preceding month
Monthly headache days
in the preceding year
Time from last headache professional consultation
in the preceding 10 years
Migraine diagnosed by headache professional
in the preceding 10 years
Age at diagnosis
from the onset of headache (time frame up to 99 years)
- +20 more secondary outcomes
Eligibility Criteria
Participant will be recruited from miscellaneous sources including: specialist headache practices, primary care clinics, patients associations. An invitation would be also extended via social and traditional media and employers.
You may qualify if:
- consent to participate in the study
You may not qualify if:
- responses missing in questionnaire
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Swiat Zdrowialead
- Wroclaw Medical Universitycollaborator
Study Sites (2)
Marcin Straburzyński
Dźwierzuty, Warmian-Masurian Voivodeship, 12-120, Poland
Department of Neurology, Wrocław Medical University
Wroclaw, Poland
Related Publications (1)
Straburzynski M, Waliszewska-Prosol M, Nowaczewska M, Czapinska-Ciepiela EK, Gryglas-Dworak A, Budrewicz S. Prevalence of cranial autonomic symptoms in frequent episodic tension-type headache: A post hoc analysis of the cross-sectional Migraine in Poland study. Dent Med Probl. 2024 Jul-Aug;61(4):489-493. doi: 10.17219/dmp/175611.
PMID: 38652923DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Marta Waliszewska-Prosół, MD, PhD
Departament of Neurolog, Wrocław Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- General practitioner
Study Record Dates
First Submitted
September 19, 2021
First Posted
October 21, 2021
Study Start
September 1, 2021
Primary Completion
April 30, 2022
Study Completion
April 30, 2022
Last Updated
May 4, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share